A common drug for high blood pressure has been mislabelled, prompting people who take it being urged to check their medication to ensure their dosage is correct, reports The Standard. One batch of the ...

GSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, ...

Maine Democrats took a step toward constitutionalizing trans athletes' protections the day after the DOJ announced a lawsuit against the state over the issue.

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...

An alert has been issued warning patients to check their medication after a misprint "error" on packaging. The "urgent" ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) says some packs of lercanidipine, manufactured by Recordati Pharmaceuticals, have been wrongly labelled as containing 10mg tablets when ...

The World Health Organization (WHO) has confirmed the redesignation of the UK’s Medicines and Healthcare products Regulatory ...

GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory ...

The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep.

Patients who take the common blood pressure medicine Lercanidipine HCI 20 mg tablets (lercanidipine hydrochloride) from the ...

The MHRA has approved eplontersen (Wainzua) for treating adults with polyneuropathy associated with hereditary transthyretin ...